Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Vaccines

Free Subscription Articles published in J Gen Virol Retrieve available abstracts of 29 articles: HTML format Text format

Single Articles

March 2010
1. BREIMAN A , Smith GL
   The vaccinia virus B5 protein affects the glycosylation, localisation and stability of the A34 protein.
   J Gen Virol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
2. FURUYA Y , Regner M, Lobigs M, Koskinen A, et al
   The effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations.
   J Gen Virol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. LOBIGS M , Pavy M, Hall RA, Lobigs P, et al
   An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralising antibody against homologous and heterologous flaviviruses.
   J Gen Virol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
4. YUSIM K , Fischer W, Yoon H, Thurmond J, et al
   Genotype 1 and Global Hepatitis C T-cell Vaccines Designed to Optimize Coverage of Genetic Diversity.
   J Gen Virol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
5. BACHY V , Ballerini C, Gourdain P, Prignon A, et al
   Mouse vaccination with dendritic cells loaded with prion protein (PrP) peptides overcomes tolerance and delays scrapie.
   J Gen Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. ZHANG Y , Wang HY, Zhu SL, Li Y, et al
   Characterization of a Rare Natural Intertypic Type 2/Type 3 Penta-Recombinant Vaccine-Derived Poliovirus Isolated from a Child with Acute Flaccid Paralysis.
   J Gen Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. BACKES S , Sperling KM, Zwilling J, Gasteiger G, et al
   Viral host range factors C7 or K1 are essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit PKR-mediated eIF2{alpha} phosphorylation.
   J Gen Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
8. JONES A , Lowry K, Aaskov JG, Holmes EC, et al
   Molecular evolutionary dynamics of Ross River virus and implications for vaccine efficacy.
   J Gen Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   August 2009
9. CHAMBERS P , Rima BK, Duprex WP
   Molecular differences between two Jeryl Lynn mumps virus vaccine component strains JL5 and JL2.
   J Gen Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. MANSFIELD KL , Johnson N, Phipps LP, Stephenson JR, et al
    Tick-borne encephalitis virus - a review of an emerging zoonosis.
    J Gen Virol. 2009;90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. SAVOLAINEN-KOPRA C , Samoilovich E, Kahelin H, Hiekka AK, et al
    Comparison of poliovirus recombinants: accumulation of point mutations provides further advantages.
    J Gen Virol. 2009;90.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
12. FINSTERBUSCH T , Wolbert A, Deitemeier I, Meyer K, et al
    Measles viruses of genotype H1 evade recognition by vaccine-induced neutralizing antibodies targeting the linear haemagglutinin noose epitope.
    J Gen Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. ADAMO JE , Meseda CA, Weir JP, Merchlinsky MJ, et al
    Smallpox vaccines induce antibodies to the immunomodulatory, secreted vaccinia virus complement control protein.
    J Gen Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
14. JOZWIK A , Manteufel J, Selbitz HJ, Truyen U, et al
    Vaccination against porcine parvovirus protects against disease but does not prevent infection and virus shedding after challenge infection with a heterologous virus strain.
    J Gen Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
15. O'BRIEN L , Perkins S, Williams A, Eastaugh L, et al
    Alpha interferon as an adenovirus-vectored vaccine adjuvant and antiviral in Venezuelan equine encephalitis virus infection.
    J Gen Virol. 2009;90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. DAMON IK , Davidson WB, Hughes CM, Olson VA, et al
    Evaluation of smallpox vaccines using variola neutralization.
    J Gen Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
17. KNUTSON BA , Oh J, Broyles SS
    Downregulation of vaccinia virus intermediate and late promoters by host transcription factor YY1.
    J Gen Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. ROBERTS KL , Breiman A, Carter G, Ewles H, et al
    Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane.
    J Gen Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. MULLER WJ , Dong L, Vilalta A, Byrd B, et al
    Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection.
    J Gen Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. KEKARAINEN T , Martinez-Guino L, Segales J
    Swine torque teno virus detection in pig commercial vaccines, enzymes for laboratory use and human drugs containing components of porcine origin.
    J Gen Virol. 2009;90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. BONNE N , Shearer P, Sharp M, Clark P, et al
    Assessment of recombinant beak and feather disease virus capsid protein as a vaccine for psittacine beak and feather disease.
    J Gen Virol. 2009;90.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
22. KOOPMAN G , Mortier D, Hofman S, Koutsoukos M, et al
    Acute phase CD4 T-cell proliferation and CD152 upregulation predict set point virus replication, in vaccinated SHIV89.6p infected macaques.
    J Gen Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. BURGERS WA , Chege GK, Muller TL, van Harmelen JH, et al
    Broad, high-magnitude and multifunctional CD4+ and CD8+ T-cell responses elicited by a DNA and modified vaccinia Ankara vaccine containing human immunodeficiency virus type 1 subtype C genes in baboons.
    J Gen Virol. 2009;90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. GRUJIC M , Holst PJ, Christensen JP, Thomsen AR, et al
    Fusion of a viral antigen to invariant chain leads to augmented T-cell immunity and improved protection in gene-gun DNA-vaccinated mice.
    J Gen Virol. 2009;90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. WRESSNIGG N , Shurygina AP, Wolff T, Redlburger-Frity M, et al
    Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice.
    J Gen Virol. 2009;90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. HUTSON CL , Olson VA, Carroll DS, Abel JA, et al
    A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus.
    J Gen Virol. 2009;90.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
27. HON CC , Lam TT, Yip CW, Wong RT, et al
    Phylogenetic evidence for homologous recombination within the family Birnaviridae.
    J Gen Virol. 2008;89.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. SUNDLING C , Schon K, Morner A, Forsell MN, et al
    CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization.
    J Gen Virol. 2008;89.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
29. ROBINSON KE , Meers J, Gravel JL, McCarthy FM, et al
    The essential and non-essential genes of Bovine herpesvirus 1.
    J Gen Virol. 2008;89.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: